40 research outputs found
Metaciclogénesis: un proceso fundamental en la biología de Leishmania
Metacyclogenesis is a process whereby Leishmania transforms from poorly infective procyclic promastigotes into highly infective metacyclic promastigotes. In nature, metacyclogenesis occurs in the insect vector. This transformation is accompanied by an increased ability to infect and survive in the vertebrate host, where the parasite is attacked by the host's immune system. Metacyclogenesis has also been shown to occur in axenic cultures of promastigotes. Morphological changes in size and shape, and length of flagellum were first associated with differentiation in the insect gut and in different phases of growth in culture. Later, the expression of molecules such as LPG and the surface protease gp63 were associated with this process. These two molecules were observed to undergo qualitative and quantitative modifications as the promastigotes differentiated from procyclic to metacyclic forms. Using cDNA subtractive hybridization-based methods or differential amplification, previously unknown genes tightly linked to metacyclogenesis have been identified. Gene products exclusively expresed in metacyclic promastigotes included a gene B product and Mat-1 -a gene associated with metacyclogenesis. Other proteins, Meta-1, SHERP and HASP, were up-regulated during the metacyclic stage. The function and stage-regulated expression of these molecules and their relationship with infectivity are now under investigation.La metaciclogénesis es un proceso que experimentan naturalmente los promastigotes de Leishmania en el tracto digestivo del insecto vector y cuya finalidad es transformar los promastigotes en formas altamente infectivas y capaces de sobrevivir en el hospedero vertebrado, donde es sometido a los ataques por parte del sistema inmune. Se ha demostrado que este fenómeno ocurre también en promastigotes en crecimiento en cultivos axénicos in vitro. El proceso de metaciclogénesis se asoció inicialmente con cambios morfológicos, observándose que los promastigotes cambiaban su forma y tamaño con incremento en la longitud del flagelo. Luego, se logró asociar con este fenómeno la expresión de ciertas moléculas implicadas en virulencia, como el lipofosfoglicano (LPG) y una proteasa de superficie, la gp63. Se demostró que estas moléculas experimentaban cambios tanto cuantitativos como cualitativos a medida que los promastigotes se diferencian de promastigotes procíclicos no infectivos a metacíclicos o infectivos. Hoy en día, mediante técnicas de hibridización substractiva con cADN o de amplificación diferencial, se han logrado identificar genes cuyo patrón de expresión está íntimamente ligado al proceso de metaciclogénesis. Se han identificado moléculas como el producto del gen B y una proteína asociada con la metaciclogénesis (Mat-1), las cuales se expresan exclusivamente en promastigotes metacíclicos, mientras que otras como las proteínas Meta-1, SHERP y HASP se sobrexpresan en los promastigotes metacíclicos. Sin embargo, la función y asociación de estas proteínas con este patrón particular de expresión y virulencia se está empezando a evaluar
Identification of Potential Kinase Inhibitors within the PI3K/AKT Pathway of Leishmania Species
Leishmaniasis is a public health disease that requires the development of more effective treatments and the identification of novel molecular targets. Since blocking the PI3K/AKT pathway has been successfully studied as an effective anticancer strategy for decades, we examined whether the same approach would also be feasible in Leishmania due to their high amount and diverse set of annotated proteins. Here, we used a best reciprocal hits protocol to identify potential protein kinase homologues in an annotated human PI3K/AKT pathway. We calculated their ligandibility based on available bioactivity data of the reported homologues and modelled their 3D structures to estimate the druggability of their binding pockets. The models were used to run a virtual screening method with molecular docking. We found and studied five protein kinases in five different Leishmania species, which are AKT, CDK, AMPK, mTOR and GSK3 homologues from the studied pathways. The compounds found for different enzymes and species were analysed and suggested as starting point scaffolds for the design of inhibitors. We studied the kinases’ participation in protein–protein interaction networks, and the potential deleterious effects, if inhibited, were supported with the literature. In the case of Leishmania GSK3, an inhibitor of its human counterpart, prioritized by our method, was validated in vitro to test its anti-Leishmania activity and indirectly infer the presence of the enzyme in the parasite. The analysis contributes to improving the knowledge about the presence of similar signalling pathways in Leishmania, as well as the discovery of compounds acting against any of these kinases as potential molecular targets in the parasite.Fil: Ochoa, Rodrigo. Universidad de Antioquia; ColombiaFil: Ortega Pajares, Amaya. University of Melbourne; AustraliaFil: Castello, Florencia Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales; Argentina. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Cálculo; ArgentinaFil: Serral, Federico. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales; Argentina. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Cálculo; ArgentinaFil: Fernández Do Porto, Darío Augusto. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales; Argentina. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Cálculo; Argentina. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Departamento de Química Biológica; ArgentinaFil: Villa Pulgarin, Janny A.. Coorporación Universitaria Remington; ColombiaFil: Varela M., Rubén E.. Universidad Santiago de Cali; ColombiaFil: Muskus, Carlos. Universidad de Antioquia; Colombi
CC8 MRSA Strains Harboring SCCmec Type IVc are Predominant in Colombian Hospitals
BACKGROUND: Recent reports highlight the incursion of community-associated MRSA within healthcare settings. However, knowledge of this phenomenon remains limited in Latin America. The aim of this study was to evaluate the molecular epidemiology of MRSA in three tertiary-care hospitals in Medellín, Colombia. METHODS: An observational cross-sectional study was conducted from 2008-2010. MRSA infections were classified as either community-associated (CA-MRSA) or healthcare-associated (HA-MRSA), with HA-MRSA further classified as hospital-onset (HAHO-MRSA) or community-onset (HACO-MRSA) according to standard epidemiological definitions established by the U.S. Centers for Disease Control and Prevention (CDC). Genotypic analysis included SCCmec typing, spa typing, PFGE and MLST. RESULTS: Out of 538 total MRSA isolates, 68 (12.6%) were defined as CA-MRSA, 243 (45.2%) as HACO-MRSA and 227 (42.2%) as HAHO-MRSA. The majority harbored SCCmec type IVc (306, 58.7%), followed by SCCmec type I (174, 33.4%). The prevalence of type IVc among CA-, HACO- and HAHO-MRSA isolates was 92.4%, 65.1% and 43.6%, respectively. From 2008 to 2010, the prevalence of type IVc-bearing strains increased significantly, from 50.0% to 68.2% (p = 0.004). Strains harboring SCCmec IVc were mainly associated with spa types t1610, t008 and t024 (MLST clonal complex 8), while PFGE confirmed that the t008 and t1610 strains were closely related to the USA300-0114 CA-MRSA clone. Notably, strains belonging to these three spa types exhibited high levels of tetracycline resistance (45.9%). CONCLUSION: CC8 MRSA strains harboring SCCmec type IVc are becoming predominant in Medellín hospitals, displacing previously reported CC5 HA-MRSA clones. Based on shared characteristics including SCCmec IVc, absence of the ACME element and tetracycline resistance, the USA300-related isolates in this study are most likely related to USA300-LV, the recently-described 'Latin American variant' of USA300
Eco-epidemiological analysis of rickettsial seropositivity in rural areas of Colombia: A multilevel approach
ABSTARCT: Rickettsiosis is a re-emergent infectious disease without epidemiological surveillance in Colombia. This disease is generally undiagnosed and several deadly outbreaks have been reported in the country in the last decade. The aim of this study is to analyze the eco-epidemiological aspects of rickettsial seropositivity in rural areas of Colombia where outbreaks of the disease were previously reported. A cross-sectional study, which included 597 people living in 246 households from nine hamlets in two municipalities of Colombia, was conducted from November 2015 to January 2016. The survey was conducted to collect sociodemographic and household characteristics (exposure) data. Blood samples were collected to determine the rickettsial seropositivity in humans, horses and dogs (IFA, cut-off = 1/128). In addition, infections by rickettsiae were detected in ticks from humans and animals by real-time PCR targeting gltA and ompA genes. Data was analyzed by weighted multilevel clog-log regression model using three levels (person, household and hamlets) and rickettsial seropositivity in humans was the main outcome. Overall prevalence of rickettsial seropositivity in humans was 25.62% (95%CI 22.11-29.12). Age in years (PR = 1.01 95%CI 1.01-1.02) and male sex (PR = 1.65 95%CI 1.43-1.90) were risk markers for rickettsial seropositivity. Working outdoors (PR = 1.20 95%CI 1.02-1.41), deforestation and forest fragmentation for agriculture use (PR = 1.75 95%CI 1.51-2.02), opossum in peridomiciliary area (PR = 1.56 95%CI 1.37-1.79) and a high proportion of seropositive domestic animals in the home (PR20-40% vs 40% vs <20% = 3.14 95%CI 2.43-4.04) were associated with rickettsial seropositivity in humans. This study showed the presence of Rickettsia antibodies in human populations and domestic animals. In addition, different species of rickettsiae were detected in ticks collected from humans and animals. Our results highlighted the role of domestic animals as sentinels of rickettsial infection to identify areas at risk of transmission, and the importance of preventive measures aimed at curtailing deforestation and the fragmentation of forests as a way of reducing the risk of transmission of emergent and re-emergent pathogens
In Vitro and In Vivo Efficacy of Ether Lipid Edelfosine against Leishmania spp. and SbV-Resistant Parasites
Leishmaniasis represents a major international health problem, has a high morbidity and mortality rate, and is classified as an emerging and uncontrolled disease by the World Health Organization. The migration of population from endemic to nonendemic areas, and tourist activities in endemic regions are spreading the disease to new areas. Unfortunately, treatment of leishmaniasis is far from satisfactory, with only a few drugs available that show significant side-effects. Here, we show in vitro and in vivo evidence for the antileishmanial activity of the ether phospholipid edelfosine, being effective against a wide number of Leishmania spp. causing cutaneous, mucocutaneous and visceral leishmaniasis. Our experimental mouse and hamster models demonstrated not only a significant antileishmanial activity of edelfosine oral administration against different wild-type Leishmania spp., but also against parasites resistant to pentavalent antimonials, which constitute the first line of treatment worldwide. In addition, edelfosine exerted a higher antileishmanial activity and a lower proneness to generate drug resistance than miltefosine, the first drug against leishmaniasis that can be administered orally. These data, together with our previous findings, showing an anti-inflammatory action and a very low toxicity profile, suggest that edelfosine is a promising orally administered drug for leishmaniasis, thus warranting clinical evaluation
Identification of a RAC/AKT-like gene in Leishmania parasites as a putative therapeutic target in leishmaniasis
[Background]: Leishmaniasis is one of the world’s most neglected diseases caused by at least 20 different species of the protozoan parasite Leishmania. Although new drugs have become recently available, current therapy for leishmaniasis is still unsatisfactory. A subgroup of serine/threonine protein kinases named as related to A and C protein kinases (RAC), or protein kinase B (PKB)/AKT, has been identified in several organisms including Trypanosoma cruzi parasites. PKB/AKT plays a critical role in mammalian cell signaling promoting cell survival and is a major drug target in cancer therapy. However, the role of protozoan parasitic PKB/AKT remains to be elucidated.[Results]: We have found that anti-human AKT antibodies recognized a protein of about 57 kDa in Leishmania spp. parasites. Anti-human phospho-AKT(Thr308) antibodies identified a protein in extracts from Leishmania spp. that was upregulated following parasite exposure to stressful conditions, such as nutrient deprivation or heat shock. Incubation of AKT inhibitor X with Leishmania spp. promastigotes under stressful conditions or with Leishmania-infected macrophages led to parasite cell death. We have identified and cloned a novel gene from Leishmania donovani named Ld-RAC/AKT-like gene, encoding a 510-amino acid protein of approximately 57.6 kDa that shows a 26.5% identity with mammalian AKT1. Ld-RAC/AKT-like protein contains major mammalian PKB/AKT hallmarks, including the typical pleckstrin, protein kinase and AGC kinase domains. Unlike mammalian AKT that contains key phosphorylation sites at Thr308 and Ser473 in the activation loop and hydrophobic motif, respectively, Ld-RAC/AKT-like protein has a Thr residue in both motifs. By domain sequence comparison, we classified AKT proteins from different origins in four major subcategories that included different parasites.[Conclusions]: Our data suggest that Ld-RAC/AKT-like protein represents a Leishmania orthologue of mammalian AKT involved in parasite stress response and survival, and therefore could become a novel therapeutic and druggable target in leishmaniasis therapy. In addition, following comparative sequence analyses, we found the RAC/AKT-like proteins from Leishmania constitute a subgroup by themselves within a general AKT-like protein family.This work was financially supported by the Ministerio de Economía y Competitividad of Spain (SAF2011–30518 and SAF2014–59716-R), Instituto de Salud Carlos III (RD12/0036/0065 from Red Temática de Investigación Cooperativa en Cáncer - RTICC, co-funded by the EU’s European Regional Development Fund - FEDER; RD16/0027/0018 from Red de Investigación Colaborativa en Enfermedades Tropicales - RICET), IBSAL (IBY15/00003), and COLCIENCIAS-Colombia (project number: 111556934507).Peer reviewe
Leishmania: papel de la glicoproteína P en la mediación de resistencia a medicamentos y estrategias de reversión.
Protozoan parasites are important causative agents of morbidity and mortality throughout the world--a problem further complicated by the emergence of drug resistance in these parasites. Mechanisms of drug resistance include the following: decreased uptake of the drug into the cell, loss of drug activation, alterations in the drug target, and over-expression of a well-known multiple drug transporter proteins. In this review, two critical components of resistance are stressed: (1) the role of ATP binding cassette proteins, such as P-glycoproteins, in mediating drug resistance in Leishmania and other protozoans, followed by development of cross-resistance to many structurally and functionally unrelated drugs, and (2) some concepts concerning the reversal mechanism of multidrug resistance by drugs and natural products. Several modulators or chemosensitizers alter the capacity of P-glycoproteins to maintain subtoxic intracellular drug concentrations. Calcium channel blockers such as verapamil act in this mode; however, high concentrations are required for an efficient and effective inhibition and, in addition, produce undesirable side effects. The discovery of new, natural product modulators of P-glycoproteins is stressed. This category of modulators offer potentially improved efficacy and lowered toxicity for the mammalian host.Actualmente, los parásitos protozoarios son uno de los principales agentes causantes de morbilidad y mortalidad en el mundo, un problema complicado, además, por la aparición de resistencia a medicamentos en estos organismos. La resistencia a medicamentos observada en parásitos protozoarios se debe a diferentes mecanismos como la disminución de la entrada del medicamento a la célula por cambios en el transportador requerido, la perdida de la activación del medicamento por parte del hospedero, las alteraciones en el blanco del medicamento y la expresi6n exagerada del transportador múltiple de medicamentos o glicoproteína P (Pgp). En esta revisión, nos centramos en: 1) el papel de las glicoproteínas P (Pgp) de la familia de proteínas ABC (ATP binding cassette) como los transportadores de múltiples medicamentos en la mediaci6n de resistencia en protozoarios, especialmente en Leishmania, y en el desarrollo de resistencia cruzada para medicamentos estructural y funcionalmente no relacionados, y 2) en algunos conceptos relacionados con los mecanismos moduladores que podrían revertir la resistencia a medicamentos por fármacos y productos naturales. Numerosos moduladores o quimio sensibilizadores son conocidos por alterar la capacidad de las glicoproteínas P para mantener concentraciones intracelulares subtóxicas del medicamento; algunos ejemplos incluyen los bloqueadores de los canales de calcio como el verapamilo; sin embargo, se requieren altas concentraciones para una inhibición eficiente y duradera, las cuales producen efectos adversos indeseables. Por tanto, se necesitan mas investigaciones relacionadas con los moduladores naturales para Pgp, los cuales podrían presentar menor toxicidad para el hospedero
Metabolite Biomarkers of Leishmania Antimony Resistance
Leishmania parasites cause leishmaniasis, one of the most epidemiologically important neglected tropical diseases. Leishmania exhibits a high ability of developing drug resistance, and drug resistance is one of the main threats to public health, as it is associated with increased incidence, mortality, and healthcare costs. The antimonial drug is the main historically implemented drug for leishmaniasis. Nevertheless, even though antimony resistance has been widely documented, the mechanisms involved are not completely understood. In this study, we aimed to identify potential metabolite biomarkers of antimony resistance that could improve leishmaniasis treatment. Here, using L. tropica promastigotes as the biological model, we showed that the level of response to antimony can be potentially predicted using 1H-NMR-based metabolomic profiling. Antimony-resistant parasites exhibited differences in metabolite composition at the intracellular and extracellular levels, suggesting that a metabolic remodeling is required to combat the drug. Simple and time-saving exometabolomic analysis can be efficiently used for the differentiation of sensitive and resistant parasites. Our findings suggest that changes in metabolite composition are associated with an optimized response to the osmotic/oxidative stress and a rearrangement of carbon-energy metabolism. The activation of energy metabolism can be linked to the high energy requirement during the antioxidant stress response. We also found that metabolites such as proline and lactate change linearly with the level of resistance to antimony, showing a close relationship with the parasite’s efficiency of drug resistance. A list of potential metabolite biomarkers is described and discussed
FLEBOTOMÍNEOS (DIPTERA: PSYCHODIDAE) EN LA RESERVA NATURAL DEL CAÑÓN DEL RÍO CLARO (ANTIOQUIA), COLOMBIA PHLEBOTOMINAE SAND FLIES (DIPTERA: PSYCHODIDAE) IN THE NATURE RESERVE AREA OF RÍO CLARO (ANTIOQUIA), COLOMBIA
Por la endemicidad de la leishmaniasis en el departamento de Antioquia (Colombia), es importante conocer la distribución actualizada de las diferentes especies de flebotomíneos, aspecto de interés para establecer su papel en la epidemiología de la enfermedad. En este trabajo se actualiza la composición de flebotomíneos de los géneros Lutzomyia y Brumptomyia en la reserva Natural del Cañón del Río Claro (Antioquia), con base en muestreos entomológicos realizados en los meses de mayo, junio y agosto de 2008. Los insectos fueron recolectados empleando trampas de luz tipo CDC y Shannon. También se realizó una búsqueda activa con aspiradores bucales en huecos y raíces tabulares de árboles. Se registra, por primera vez en la zona, la presencia de las especies Lutzomyia ayrozai, L. camposi, L. carrerai thula, L. dasymera, L. isovespertilionis, L. micropyga, L. olmeca bicolor, L. cayennensis cayennensis, L. pilosa y L. shannoni. Así mismo, se informa el primer hallazgo de las especies Brumptomyia hamata y B. mesai en este departamento y se resalta la presencia de L. gomezi, L. hartmanni, L. panamensis, L. trapidoi y L. yuilli, vectores potenciales de leishmaniasis cutánea en Colombia. Se destaca la permanencia de L. longipalpis (Lutz y Neiva), vector de Leishmania infantum, agente causal de leishmaniasis visceral, luego de su registro inicial en la zona más de diez años atrás.<br>Considering the endemicity of leishmaniasis in the Antioquia region, Colombia, it is important to have an updated distribution of different phlebotomine sand fly species, as their distribution is a relevant factor for establishing the role of such species in the disease epidemiology. This study evaluated the current composition of phlebotomine sand flies of the genera Lutzomyia and Brumptomyia in the natural reserve of the Río Claro Canyon (Antioquia), following entomological surveys in May, June, and August of 2008. Insects were collected using light traps such as CDC and Shannon, and through active searches using mouth aspirators as collecting devices on substrates such as tree holes and buttresses. We provide the first record of Lutzomyia ayrozai, L. camposi, L. carrerai thula, L. dasymera, L. isovespertilionis, L. micropyga, L. olmeca bicolor, L. cayennensis cayennensis, L. pilosa, and L. shannoni in the reserve of Río Claro. We also report the first finding of Brumptomyia hamata and B. mesai in the Antioquia region, highlighting the occurrence of L. gomezi, L. hartmanni, L. panamensis, L. trapidoi, and L. yuilli because these species are known as potential vectors of cutaneous leishmaniasis in Colombia. Documenting the presence of L. longipalpis (Lutz and Neiva) ten years after its previous record in the area is noteworthy, given that this species is the vector of Leishmania infantum, the aetiological agent of visceral leishmaniasi
Detection in silico of second use drugs with potential anti-leishmania activity
Actualmente las enfermedades tropicales son objeto de importantes investigaciones en las ciencias biomédicas,
debido al impacto global que causa en poblaciones vulnerables. Sin embargo son comúnmente ignoradas por la industria
farmacéutica debido a su bajo potencial de rentabilidad económica. Por esta razón, la búsqueda de nuevos tratamientos terapéuticos
por medios costo-efectivos es esencial para la lucha contra parásitos tropicales como Leishmania spp. En este trabajo se hizo una
búsqueda y selección de medicamentos depositados en bases de datos públicas, y cuyo blanco de acción demostrado son proteínas
conocidas. Con estas proteínas blanco de medicamentos, se hizo una búsqueda de ortólogos en el proteoma de Leishmania, con el
fi n de identifi car rápidamente medicamentos que pudieran tener acción también contra este parásito, implementando herramientas
in silico, basadas en la Bioinformática. También en el caso de poseer la estructura de las proteínas de interés, se realizó análisis
de docking para corroborar la interacción con el medicamento. Empleando esta estrategia, se identifi caron y seleccionaron 10
medicamentos que son evaluados actualmente en ensayos in vitro.Currently, tropical diseases are a major subject of research in biomedical sciences due to its global impact on
vulnerable populations. However, these diseases are normally ignored by pharmaceutical companies due to low profi tability
potential. For that reason, the search of new therapeutic treatments, that are cost-effective, is essential to fi ght against tropical
parasites as Leishmania spp. In this work, a search and selection of drugs with known protein targets, which were deposited in
public databases, was conducted. With these target proteins, a search for orthologs in the Leishmania proteome was carried out
in order to identify drugs that could also have anti-leishmanial activity. For this purpose bioinformatics tools were implemented.
In addition, in the case that Leishmania proteins have its tridimensional structure reported, docking analysis were simulated to
corroborate interaction with the drug. At the end, a selection of 10 drugs was identifi ed and is currently being evaluated in in vitro
tes